AGP Executive Report
Last update: an hour agoUniversal Healthcare: China’s National Healthcare Security Administration unveiled its 15th Five-Year Plan (2026-2030) to strengthen universal healthcare security, with a major push toward long-term care insurance and better support for families and ageing. Rare Disease Safety: Ireland recalled the rare autoimmune drug Tavneos after links to 20 deaths reported in Japan, following EU reassessment and withdrawal of market authorisation. Cancer Innovation: Indian researchers from IASST and IIT Guwahati developed RK-251, a “smart” cancer drug candidate that stays inactive in circulation and activates inside tumour cells using high reactive oxygen species, aiming to spare healthy tissue. Healthcare Access & Coverage (US): SCAN Health Plan expanded its partnership with Costco to offer Medicare Advantage and supplement plans, including new pharmacy and vision/audiology benefits pending approvals. Digital Health & Longevity (Japan): GlycanAge and ExoEarth announced a collaboration to expand glycan-based biological age testing across Japan and run joint ageing research. Aquaculture & Public Health: Khyber Aquaculture partnered with Jammu and Kashmir’s fisheries department to train trout farmers on sustainable aquaculture and fish health management, focusing on biosecurity and early disease detection. Sports & Health Systems (India): India’s sports ministry called for a faster, structured athlete talent hunt for the 2036 Olympics, using a two-stage scouting approach from district/state levels upward.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
